DE ANGIOLETTI, MARIA
DE ANGIOLETTI, MARIA
Istituto di Chimica dei Composti OrganoMetallici - ICCOM -
Identification and characterization of novel ETV4 splice variants in prostate cancer
2023 Cosi, Irene; Moccia, Annalisa; Pescucci, Chiara; Munagala, Uday; Di Giorgio, Salvatore; Sineo, Irene; G Conticello, Silvestro; Notaro, Rosario; DE ANGIOLETTI, Maria
Myeloid tumor infiltrating cells in a mouse model of prostate cancer progression
2023 Cosi Irene; Moccia Annalisa; Nannelli Caterina; Rosini Dario; Pellecchia Annamaria; Sica Michela; Notaro Rosario; De Angioletti Maria.
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials
2023 Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; DE ANGIOLETTI, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasómaristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab
2023 Sica, Michela; Barone, Federica; Nannelli, Caterina; Ricci, Patrizia; Marano, Luana; DE ANGIOLETTI, Maria; Di Bona, Eros; M Risitano, Antonio; Notaro, Rosario
Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH
2020 Sica, Michela; Pellecchia, Annamaria; DE ANGIOLETTI, Maria; Caocci, Giovanni; Nannelli, Caterina; La Nasa, Giorgio; Luzzatto, Lucio; Notaro, Rosario
ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21
2020 Cosi, Irene; Pellecchia, Annamaria; De Lorenzo, Emanuele; Torre, Eugenio; Sica, Michela; Nesi, Gabriella; Notaro, Rosario; DE ANGIOLETTI, Maria
ETV4 over-expression promotes prostate cancer through different pathways
2019 Cosi, I; Pellecchia, A; Lorenzo, Ede; Moccia, A; Iozzo, M; Sica, M; Nannelli, C; Notaro, R; DE ANGIOLETTI, Maria
ETV4-mediated prostate cancerogenesis may involve an inflammation related gene
2019 Cosi, I; Moccia, A; Iozzo, M; Pellecchia, A; Sica, M; Nannelli, C; Notaro, R; DE ANGIOLETTI, Maria
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations
2018 Bigagli E.; Luceri C.; De Angioletti M.; Chegaev K.; D'Ambrosio M.; Riganti C.; Gazzano E.; Saponara S.; Longini M.; Luceri F.; Cinci L.
Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants.
2017 Tricarico, Rossella; Kasela, Mariann; Mareni, Cristina; Thompson, Bryony A; Drouet, Aurelie; Staderini, Lucia; Gorelli, Greta; Crucianelli, Francesca; Ingrosso, Valentina; Kantelinen, Jukka; Papi, Laura; De Angioletti, Maria; Berardi, Margherita; Gaildrat, Pascaline; Soukarieh, Omar; Turchetti, Daniela; Martins, Alexandra; Spurdle, Amanda B; Nystrom, Minna; Genuardi, Maurizio
Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
2017 Michela Sica; Tommaso Rondelli; Patrizia Ricci; Maria De Angioletti; Antonio M. Risitano;Rosario Notaro
Effects of NO and H2S releasing doxorubicin on a xenograft model of chemoresistant prostate cancer
2017 Cinci, L; Bigagli, E; DE ANGIOLETTI, Maria; Chegaev, K; Riganti, C; D'Ambrosio, M; Saponara, S; Luceri, C
ETV4 over-expression in prostate cells down-regulates p21 both in vitro and in vivo
2017 Pellecchia, A; Cosi, I; De Lorenzo, E; Sica, M; Notaro, R; DE ANGIOLETTI, Maria
CD59 Deficiency Is Critical for C3 Binding on Red Blood Cells of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) during Anti-C5 Treatment (eculizumab)
2016 Sica, MIchela; Rondelli, Tommaso; Ricci, Patrizia; De Angioletti, Maria; Risitano, Antonio M.; Notaro, Rosario
ETV4 overexpression cooperates with Pten deletion for prostate cancer progression in mice.
2015 Emanuele De Lorenzo; Annamaria Pellecchia; Irene Cosi; Chiara Pescucci; Eugenio Torre; Gabriella Nesi; Rosario Notaro; Maria De Angioletti
Recent advances in pathogenesis of paroxysmal nocturnal hemoglobinuria
2015 Notaro, Rosario; Gargiulo, Lucia; De Angioletti, Maria; Rondelli, Tommaso; Sica, Michela
Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab
2014 Sica, Michela; Pellecchia, Annamaria; Berardi, Margherita; Gargiulo, Lucia; Olutogun, Tolulase A.; Caocci, Giovanni; La Nasa, Giorgio; De Angioletti, Maria; Luzzatto, Lucio; Notaro, Rosario
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CLINICAL EXPRESSION AND RESPONSE TO TREATMENT ARE MODIFIED BY A UNIQUE INTERACTION WITH CO-EXISTING GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY
2014 Sica, M; Pellecchia, A; Berardi, M; Gargiulo, L; Olutogun, T A; Caocci, G; La Nasa, G; De Angioletti, M; Luzzatto, L; Notaro, R
Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
2014 Rondelli, Tommaso; Risitano Antonio, Maria; Peffault de Latour, Regis; Sica, Michela; Peruzzi, Benedetta; Ricci Patrizia Barcellini, Wanda; Iori Anna, Paola; Boschetti, Carla; Valle, Veronica; Frémeauxbacchi, Veronique; DE ANGIOLETTI, Maria; Socié, Gerard; Luzzatto, Lucio; Notaro, Rosario
Identification and molecular characterization of a novel 55 kb deletion recurrent in Southern Italy: the Italian Ggamma(Agamma delta beta)°-thalassemia.
2013 Lacerra, Giuseppina; Prezioso, Romeo; Musollino, Gennaro; Mastrullo, Lucia; Piluso, Giulio; DE ANGIOLETTI, Maria
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Identification and characterization of novel ETV4 splice variants in prostate cancer | 1-gen-2023 | Cosi, Irene; Moccia, Annalisa; Pescucci, Chiara; Munagala, Uday; Di Giorgio, Salvatore; Sineo, Irene; G Conticello, Silvestro; Notaro, Rosario; DE ANGIOLETTI, Maria | |
Myeloid tumor infiltrating cells in a mouse model of prostate cancer progression | 1-gen-2023 | Cosi Irene; Moccia Annalisa; Nannelli Caterina; Rosini Dario; Pellecchia Annamaria; Sica Michela; Notaro Rosario; De Angioletti Maria. | |
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials | 1-gen-2023 | Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; DE ANGIOLETTI, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasómaristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia | |
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab | 1-gen-2023 | Sica, Michela; Barone, Federica; Nannelli, Caterina; Ricci, Patrizia; Marano, Luana; DE ANGIOLETTI, Maria; Di Bona, Eros; M Risitano, Antonio; Notaro, Rosario | |
Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH | 1-gen-2020 | Sica, Michela; Pellecchia, Annamaria; DE ANGIOLETTI, Maria; Caocci, Giovanni; Nannelli, Caterina; La Nasa, Giorgio; Luzzatto, Lucio; Notaro, Rosario | |
ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21 | 1-gen-2020 | Cosi, Irene; Pellecchia, Annamaria; De Lorenzo, Emanuele; Torre, Eugenio; Sica, Michela; Nesi, Gabriella; Notaro, Rosario; DE ANGIOLETTI, Maria | |
ETV4 over-expression promotes prostate cancer through different pathways | 1-gen-2019 | Cosi, I; Pellecchia, A; Lorenzo, Ede; Moccia, A; Iozzo, M; Sica, M; Nannelli, C; Notaro, R; DE ANGIOLETTI, Maria | |
ETV4-mediated prostate cancerogenesis may involve an inflammation related gene | 1-gen-2019 | Cosi, I; Moccia, A; Iozzo, M; Pellecchia, A; Sica, M; Nannelli, C; Notaro, R; DE ANGIOLETTI, Maria | |
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations | 1-gen-2018 | Bigagli E.; Luceri C.; De Angioletti M.; Chegaev K.; D'Ambrosio M.; Riganti C.; Gazzano E.; Saponara S.; Longini M.; Luceri F.; Cinci L. | |
Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants. | 1-gen-2017 | Tricarico, Rossella; Kasela, Mariann; Mareni, Cristina; Thompson, Bryony A; Drouet, Aurelie; Staderini, Lucia; Gorelli, Greta; Crucianelli, Francesca; Ingrosso, Valentina; Kantelinen, Jukka; Papi, Laura; De Angioletti, Maria; Berardi, Margherita; Gaildrat, Pascaline; Soukarieh, Omar; Turchetti, Daniela; Martins, Alexandra; Spurdle, Amanda B; Nystrom, Minna; Genuardi, Maurizio | |
Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes | 1-gen-2017 | Michela Sica; Tommaso Rondelli; Patrizia Ricci; Maria De Angioletti; Antonio M. Risitano;Rosario Notaro | |
Effects of NO and H2S releasing doxorubicin on a xenograft model of chemoresistant prostate cancer | 1-gen-2017 | Cinci, L; Bigagli, E; DE ANGIOLETTI, Maria; Chegaev, K; Riganti, C; D'Ambrosio, M; Saponara, S; Luceri, C | |
ETV4 over-expression in prostate cells down-regulates p21 both in vitro and in vivo | 1-gen-2017 | Pellecchia, A; Cosi, I; De Lorenzo, E; Sica, M; Notaro, R; DE ANGIOLETTI, Maria | |
CD59 Deficiency Is Critical for C3 Binding on Red Blood Cells of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) during Anti-C5 Treatment (eculizumab) | 1-gen-2016 | Sica, MIchela; Rondelli, Tommaso; Ricci, Patrizia; De Angioletti, Maria; Risitano, Antonio M.; Notaro, Rosario | |
ETV4 overexpression cooperates with Pten deletion for prostate cancer progression in mice. | 1-gen-2015 | Emanuele De Lorenzo; Annamaria Pellecchia; Irene Cosi; Chiara Pescucci; Eugenio Torre; Gabriella Nesi; Rosario Notaro; Maria De Angioletti | |
Recent advances in pathogenesis of paroxysmal nocturnal hemoglobinuria | 1-gen-2015 | Notaro, Rosario; Gargiulo, Lucia; De Angioletti, Maria; Rondelli, Tommaso; Sica, Michela | |
Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab | 1-gen-2014 | Sica, Michela; Pellecchia, Annamaria; Berardi, Margherita; Gargiulo, Lucia; Olutogun, Tolulase A.; Caocci, Giovanni; La Nasa, Giorgio; De Angioletti, Maria; Luzzatto, Lucio; Notaro, Rosario | |
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CLINICAL EXPRESSION AND RESPONSE TO TREATMENT ARE MODIFIED BY A UNIQUE INTERACTION WITH CO-EXISTING GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY | 1-gen-2014 | Sica, M; Pellecchia, A; Berardi, M; Gargiulo, L; Olutogun, T A; Caocci, G; La Nasa, G; De Angioletti, M; Luzzatto, L; Notaro, R | |
Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. | 1-gen-2014 | Rondelli, Tommaso; Risitano Antonio, Maria; Peffault de Latour, Regis; Sica, Michela; Peruzzi, Benedetta; Ricci Patrizia Barcellini, Wanda; Iori Anna, Paola; Boschetti, Carla; Valle, Veronica; Frémeauxbacchi, Veronique; DE ANGIOLETTI, Maria; Socié, Gerard; Luzzatto, Lucio; Notaro, Rosario | |
Identification and molecular characterization of a novel 55 kb deletion recurrent in Southern Italy: the Italian Ggamma(Agamma delta beta)°-thalassemia. | 1-gen-2013 | Lacerra, Giuseppina; Prezioso, Romeo; Musollino, Gennaro; Mastrullo, Lucia; Piluso, Giulio; DE ANGIOLETTI, Maria |